Montreal General Hospital
Montreal, Quebec, H3A 1A1, Canada
NCT Number: NCT01836978
The process of enhancing the functional capacity of an individual before an operation to enable him or her to withstand the stress of surgery has been termed prehabilitation. It has been shown that poor baseline capacity for physical performance and poor nutritional status increase the risk of complications after major non cardiac surgery and prolong recovery. A controlled randomized study in patients undergoing radical cystectomy for cancer is therefore proposed to determine the impact of multimodal prehabilitation on functional exercise capacity and functional recovery. Patients who accept to be enrolled in the study will be randomized to either a group receiving a multimodal intervention which includes nutritional supplementation (Immunocal® whey protein) combined with a physical exercise program and stress reduction strategies before and after surgery, or a control group who will receive standard preoperative treatment as per our institution.
Looking for future studies?
Notify Me18 year–85 year
All sexes
Interventional
Not applicable
Montreal, Quebec, H3A 1A1, Canada
Study Arms
Randomization Patients will be assigned to the two groups using a computer-generated randomization process whereby brown sealed envelopes will be prepared and opened after patients' consent has been signed.
Components of prehabilitation
The patients' nutritional status and adequacy of dietary intake will be assessed by a nutritionist using a three day food record and the Subjective Global Assessment tool. Percentage of lean body mass and fat will be measured with bioelectrical impedance. Serum albumin will also be measured. All patients in the prehabilitation group will be provided with a whey protein supplement (Immunocal®, Immunotec Inc.) and will be provided with strategies to optimize dietary energy and protein intake. The quantity of supplement the patient will be required to consume daily will depend on the estimated deficit in dietary protein intake. This will be determined based on the difference between usual protein intake and protein requirement, as assessed by the nutritionist at the baseline assessment. Patients in the control group will receive general instructions about healthy eating.
Compliance will be monitored weekly through phone calls by the study coordinator. The patients will also be asked to complete a journal detailing the quantity of nutritional supplement consumed each day.
The exercise component will consist of approximately 60 min of resistance and aerobic training, for a minimum of 3 days per week. The exercise program will be individualized based upon the baseline fitness test (according to the American College of Sport Medicine, ACMS, standard) and will include: a 5 min warm-up, either 25 min of aerobic exercise (starting at 30- 40 % of heart rate reserve, HRR), and 25 min of resistance training (8 exercises targeting major muscle groups performed at moderate intensity), and a 5-10 min cool-down and stretching period. All exercises will be clearly explained and demonstrated by the kinesiologist at baseline. Patients will be asked to carry out this program at home, unsupervised, but will be monitored with weekly telephone calls. Training intensity progression will occur when the participant can complete aerobic exercise on mild exertion and/or when the participant can complete 15 repetitions of a given resistance exercise. Participants will be provided with resistance bands and an exercise mat, as well as a pedometer and a heart rate monitor, which can be used by the participant to monitor progress and by the kinesiologist to monitor daily compliance. A log book will also be completed to report all activities and frequency of exercises completed.
The kinesiologist will follow all the participants on a weekly basis to ensure program compliance and address any barriers that may prevent ongoing participation.
The control group will receive general instructions on how to exercise during hospital stay while in bed, walking and sitting.
C. Anxiety reduction strategy.
It is expected that patients undergoing bladder surgery for cancer are anxious and depressed. The control group will receive general instructions in the preoperative clinic about the perioperative care and breathing exercises, while those in the prehabilitation group will be seen by a psychologist coordinator who will provide different strategies to deal with anxiety and depression (guided imagery, relaxation, visualization, yoga).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients in this group will follow the multimodal protocol consisting of nutritional counseling with Immunocal® whey protein supplementation, an individualized physical exercise program and stress reduction strategies.
Time frame: up to 8 weeks after surgery
The 6MWT evaluates the ability of an individual to maintain a moderate level of physical activity over a time period reflective of the activities of daily living. Subjects are instructed to walk back and forth, in a 20 m stretch of hallway, for six minutes, at a pace that would make them tired by the end of the walk
McGill University Health Centre/Research Institute of the McGill University Health Centre
Other
Prehabilitation to Enhance Postoperative Functional Capacity Following Radical Cystectomy: Combining Physical Exercise to Stress Reduction Strategies and Nutritional Supplementation
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03636256
Bladder Cancer, Cancer of the Bladder
Phoenix, Arizona, United States
View Trial DetailsNCT00462488
Bladder Cancer, Bladder Neoplasms
Tallahassee, Florida, United States
View Trial DetailsNCT05072600
Bladder Cancer, Bladder Neoplasms
Beijing, Beijing Municipality, China
View Trial DetailsNCT03924856
Bladder Cancer, Female Urogenital Diseases
La Jolla, California, United States
View Trial Details